Works matching IS 10031057 AND DT 2024 AND VI 33 AND IP 11

Results: 12

The research team of Prof. Songhai Tian published an experimental scheme to study the mechanism of bacterial toxins using pooled CRISPR perturbation screen.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1097, doi. 10.1002/advs.202405406
Publication type:: Article

The research team of Prof. Jiancheng Wang proposed a new strategy of triple amplification effects of nanomedicine on the STING signaling to enhance tumor immunotherapy.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1095, doi. 10.1002/adhm.202403143
Publication type:: Article

The research team of Prof. Zhuo Huang found that Carvedilol inhibits neonatal malignant epilepsy caused by KCNT1 mutation, providing new hope for the treatment of refractory epilepsy.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1092
Publication type:: Article

The research teams of Prof. Liangren Zhang and Prof. Zhuo Huang have made new progress in the discovery of the lead structure of Epilepsy-Associated K<sub>Na</sub>1.1 Channel.

Published in:: Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1090, doi. 10.1021/acs.jmedchem.4c01815
Publication type:: Article

Advancements in oral therapeutic drugs for treating SARS-CoV-2 infections: A comprehensive review.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1082, doi. 10.5246/jcps.2024.11.078

By:

Li Wang;
Meng Rui;
Jun Peng;
Yun Ling

Publication type:

Article

Exploring the antihypertensive mechanism of Prunella vulgaris through integrated network pharmacology analysis.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1068, doi. 10.5246/jcps.2024.11.077

By:

Na Sun;
Yujing Wang;
Caihong Zhou;
Huanhuan Kang;
Shuo Ma;
Yu Zhang;
Yuhan Yuan;
Xin Zhang;
Linxuan Jin;
Wenqian Li;
Xinru Wu;
Penghua Shu

Publication type:

Article

Exploring the evolution of animal models for gout and hyperuricemia: A bibliometric analysis.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1058, doi. 10.5246/jcps.2024.11.076

By:

Zining Peng;
Qian Deng;
Fanyu Meng;
Xingqiang Wang;
Nian Liu;
Weitian Yan;
Jiangyun Peng

Publication type:

Article

Bioinformatics-based investigation of the therapeutic potential of Tongxinluo capsule in acute myocardial infarction.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1040, doi. 10.5246/jcps.2024.11.075

By:

Jingjing Su;
Kangkang Su;
Yanping Song;
Lihui Hao;
Xing Wang;
Linquan Yang;
Chao Wang;
Shuxia Chen;
Jian Gu

Publication type:

Article

Deciphering the therapeutic mechanisms of Fructus Ligustri Lucidi on diabetic nephropathy via bioinformatics analysis.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1025, doi. 10.5246/jcps.2024.11.074

By:

Qinqing Li;
Yanli Xin;
Pulin Liu;
Kaiwen Li;
Caifang Jing;
Xuelan Zhang;
Wenbin He

Publication type:

Article

Bibliometric and visual analysis of global research on snake venom disintegrins (2009-2023).

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1012, doi. 10.5246/jcps.2024.11.073

By:

Yinxiang Lan;
Xiuliang Qiu;
Dandan Huang

Publication type:

Article

Developing a "1 + X" pharmaceutical consultation model through the PDCA cycle.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 1001, doi. 10.5246/jcps.2024.11.072

By:

Tiantian Xu;
Xiaoling Song;
Xuanying Chen;
Yanni Lv

Publication type:

Article

Synthesis of mesoporous sodium hyaluronate microspheres via electrostatic spray method.

Published in:

Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 11, p. 985, doi. 10.5246/jcps.2024.11.071

By:

Wei Huang;
Jie Zhu;
Yingshu Feng;
Dan Yang;
Firempong, Caleb Kesse;
Yang Qu;
Haibing He;
Hongfei Liu

Publication type:

Article